EFBIC RED. Workshop on Infectious Diseases ( March 17-19, 2008)

Size: px

Start display at page:

Download "EFBIC RED. Workshop on Infectious Diseases ( March 17-19, 2008)"

Toby George
6 years ago
Views:

1 EFBIC RED Workshop on Infectious Diseases ( March 17-19, 2008) Organizations Co-organization Organizers EFBIC ( European Focus on Biotechnology in China) CNCBD (China National Centre for Biotechnology Development) Chinese Academy of Engineering( CAE) Shanghai Center and the Division of Medicine and Pharmacy, CAE Prof. Yu-Mei Wen Fudan University Shanghai Medical College Institute of Medical Microbiology Ministry of Education/ Ministry of Health Key Laboratory of Medical Molecular Virology 138 Yi Xue Yuan Road Shanghai, China Prof. Qi Jin Director National Key Laboratory of Virology China CDC Prof. Hubert E. Blum Department of Medicine II University Hospital Freiburg Hugstetter Strasse 55 D Freiburg, Germany Aims In general, to review the current state of knowledge and technology on infectious diseases, and define strategies for translational research on improvement of human health. Besides, there will be monitoring, evaluation and discussion on future strategic planning of the health research practices of the EU and China. Specifically, to initiate bilateral discussions on common interests on developing collaborations on infectious diseases, including generation of joint proposals to submit to the EU 7 th program; exchange information on control policies of infectious diseases; and to promote joint ventures on small enterprises between China and EU. 1

2 Program Participants from EU to arrive on March 16, 2008 March 17, 2008 from 8:00 Registration 12:00-13:00 Lunch 14:00-14:30 Chair: H. Blum and YM Wen Welcoming addresses from organizers,introduction of EFBIC (RED) and representatives from Ministry of Science and Technology, Fudan University 14:30-18:00 Plenary session I Chair: P. Lachmann, Zong-tian Qi 14:30-14:55 Review on status of infectious diseases in China Yu Wang, Director, China CDC 14:55-15:20 Review on status of infectious diseases in EU to be determined 15 :20-15 :45 The potential of protease activation mutants of influenza virus for epidemic and pandemic live vaccines. Hans Klenk, Institut für Virologie Marburg, Germany 15:45-16:15 Break 16:15-16:40 Avian flu Fu Gao, Institute of Microbiology, Chinese Academy of Sciences 16: 40-17:05 Molecular and Clinical Aspects of Hepatitis B Virus Infection H. E. Blum, Freiburg, Germany 17:05-17:30 Interaction of HBV with the interferon system Zhenghong Yuan Key lab Mol Med Virol, Fudan University 2

3 17:30-17:55 Hepatitis C Virus Entry: Molecular Biology and Clinical Impact Th. Baumert, Strasbourg 17:55-18:20 Summary of Plenary Session I and Comments from the Audience March 18, :00-12:30 Plenary session II Chair: H Klenk, Bing Sun 9:00-09:25 Novel paradigms of vaccine development A. von Gabain, Vienna 9:25-9:50 Progress on Viral Vaccine Research and Development in China Li Ruan, China CDC 9:50-10:15 Passive Immunization against Infections P. Lachmann, Cambridge, UK 10:15-10:45 Break 10:45-11:10 High-affinity and broadly neutralizing human recombinant antibodies targeted to the key linear and conformational epitomes on Influenza A H5 hamogglutinin Mi-fang Liang, Institute of Virology, China CDC 11:10-11:35 FLUVACC/DeltaNS1- a live attenuated eplication-deficient influenza vaccine Th. Muster, Vienna, Austria 11:35-12:00 Computational vaccine design J. Soellner, Austria 12:00-12:30 Summary of Plenary Session II 12:30-14:00 Lunch and visit to small enterprise room 3

4 Chair: Th. Baumert, Shan Lu 14:00-14:25 Animal Models for therapeutic vaccination in chronic Hepatitis B M. Roggendorf, Essen, Germany 14:25-14:50 Therapeutic vaccine for viral hepatitis B Wen Yu-Mei, Fudan University, Shanghai 14:50-15:15 Intrinsic Immunity against Hepatitis B-Virus and other Retroelements D. Trono, Switzerland 15:15-15:40 Oncovirology Christopher Steininger, Medical University Vienna 15:40-16:00 Break and personal discussions 16:00-16:25 Sepsis K. Herkner, Vienna 16:25-16:50 Antimicrobial Resistance among common pathogens in China Hui Wang, PUMC, Beijing 16:50-17:15 Studies on mechanisms of bacterial drug resistance Ming-Gui Wang, Hua Shan Hospital, Shanghai 17: 15-17: 40 Latent infections of tuberculosis in China Wen-Hong Wang, Hua Shan Hospital 17:40-18:05 Research and development of new vaccines against tuberculosis through international partnership Zongming Li, Haigui Co. Shanghai 18:05-18:30 Human granulocytic anaplasmosis in China Jianguo Xu, State Key Laboratory for Infectious Diseases Prevention and Control, National Institute of Communicable Disease Control and Prevention, China CDC. 18: 30-18:50 Summary on plenary session II 19:30 Dinner, hosted by CAE-SHA 4

5 March 19, 2008 Chair: Thomas Muster, Zhi-Kai Xu 9:25-9:50 The future of synthetic biology: what more do we need? Antoine Danchin, Pasteur Instittute, France 9:50-10:20 Cytomegalovirus infection and immunosenescence in humans Claudio Franceschi, Lausanne, Switzerland 10:20-10:45 Break 10:20-12:00 Free presentation from participants and discussion Hua Tang, Bing Sun, Shan Lu, Fu-quan Hu, Yi-Xue Li et al 12:00-14:00 Lunch 14:00-16:00 Discussion on potential joint proposals to submit to the EU 7 th program Possible topics: new vaccine developments, passive immunization, control adnd survy of respiratory infections, control of resistance to antimicrobial drugs 16:00-16:45 Beak and personal discussions 16:45-18:00 Chair: H. Blum, YM Wen Summary and closing remarks Expected Participants Around 30 scientists from EU and around 80 scientists from China Budget and financial support European scientists and officials: Travel to Shanghai and accommodation in Shanghai to be discussed with EFBIC (Brian Clark) Chinese scientists: Travel to Shanghai and accommodation in Shanghai by grants from scientists 5

6 Meeting room facility, meeting abstracts, welcome dinner, and invited speakers from the Ministry of Science and Technology, Ministry of Health, and other guests will be supported by CNCBD Sponsors from industries are welcome During the meeting, there will be a room from March for industries to display brochures and to meet with potential partners or guests. Speakers & Moderators Blum Hubert E Department of Medicine II University Hospital Freiburg Hugstetter Strasse 55 D Freiburg, Germany hubert.blum@uniklinik-freiburg.de Prof. Dr. Thomas F. Baumert Directeur, INSERM Unité 748 Centre Hospitalier Universitaire Université Louis Pasteur 3 Ru de Koeberle F Strasbourg France Thomas.Baumert@viro-ulp.u-strasbg.fr Prof Qi Jin Director National Key Laboratory of Virology China CDC Prof Wen Yu-Mei Fudan University Shanghai Medical College Institute of Medical Microbiology Ministry of Education/ Ministry of Health Key Laboratory of Medical Molecular Virology 138 Yi Xue Yuan Road Shanghai, China ymwen@shmu.edu.cn 6

7 Prof. Dr. Michael Roggendorf Universitätsklinikum Essen Robert-Koch-Haus Hufelandstraße Essen Germany Prof. Dr. Alexander von Gabain Intercell AG Campus Vienna Biocenter 2 A-1030 Wien Österreich AGABAIN@intercell.com Sir Peter Lachmann FRS FMedSci Department of Veterinary Medicine Madingley Road Cambridge CB3 0ES United Kingdom pj11000@cam.ac.uk Prof. Dr. H. D. Klenk Institut für Virologie Hans-Meerwein-Straße 2 D Marburg / Germany klenk@staff.uni-marburg.de Prof. Dr. Kurt Herkner Hauptlabor und FCU für Pädiatrische Biochemie & Analytik Universitätsklinik für Kinder- und Jugendheilkunde Währinger Gürtel A-1090 Wien Austria kurt.herkner@meduniwien.ac.at Dr. Johannes Soellner Emergentec Biodevelopment GmbH Rathausstraße 5/3 A-1010 Wien Austria Johannes.soellner@emergentec.com Dr. Thomas Muster CEO/CSO AVIR Green Hills Biotechnology Gersthofer Straße A-1180 Wien Austria t.muster@greenhillsbiotech.com 7

8 Prof. Dr. Didier Trono Faculté des Sciences de la Vie EPFL SG Station 15 CH Lausanne Switzerland didier.trono@epfl.ch Prof Yu Wang, Director, China CDC Prof Fu Gao, Director, Institute of Microbiology, Chinese Academy ofsciences Prof Zhengyong Yuan, Professor. Director, Key lab Mol Med Virol, Ministry of Education/ Ministry of Health, Fudan University Prof Mi-fang Liang, Institute of Virology, China CDC Dr. Zongming Li, CEO Haigui Co. Shanghai Professor Hui Wang, Head, Laboratory of Clinical Microbiology Diagnosis, Peking Union Medcial College, Beijing Prof Minggui Wang, Director, Key Laboratory of Antibiotic Resistance, Minmistry of Health, Hua Shan Hospital, Fudan University, Shanghai Prof Jianguo Xu, State Key Laboratory for Infectious Diseases Prevention and Control, National Institute of Communicable Disease Control and Prevention, China CDC. Prof Wen-Hong Wang, Professor, Department fo Infectious Diseases, Hua shan Hospital Prof Bing Sun, Co-director, Shanghai-Pasteur Institute Prof Zhi-Kai Xu, Chair, Department of Microbiology, Fourth Military Medical University Prof. Zong-tian Qi, Chair, Department of Microbiology, Second Militaory Medical University Prof Shan Lu, Advisor, Deparment of Nanjing Medical University Other professors and doctors from Hangzhou, Zhejiang Chengdu,Sichuan;Wuhan, Hubei; Tianjin Hebei; Nanjing Jiangsu; Guangzhou, Guangdong; Xian, Shanxi; have responded to attend this Workshop. 8

Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security

Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security May 17-19 2017, Wuhan, China Meeting Program Note: Each report will take 25 minutes including